Clinical Trials Directory

Trials / Sponsors / Aura Biosciences

Aura Biosciences

Industry · 9 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Choroidal Melanoma, Indeterminate Lesions
—2026-02-01
RecruitingChoroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma
—2025-11-12
RecruitingSuprachoroidal Administration in Subjects With Metastases to the Choroid
Eye Cancer, Primary Cancer
Phase 22024-12-16
RecruitingA Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-0
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma
Phase 32023-12-06
RecruitingA Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Non-muscle-invasive Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma
Phase 12022-09-26
TerminatedProspective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Prima
Choroidal Melanoma, Indeterminate Lesions
—2022-04-14
CompletedPhase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With P
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
Phase 22020-08-05
RecruitingA Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Choroidal Melanoma, Indeterminate Lesions of Eye
—2019-03-27
CompletedStudy in Subjects With Small Primary Choroidal Melanoma
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
Phase 1 / Phase 22017-02-27